Abstract : The virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the source of COVID-19. It was first discovered in Wuhan, the Chinese province of Hubei, in December 2019, and in 2019–20 it spread to other parts of the world and became a pandemic [1]. The WHO officially designated it COVID-19 on February 11, 2020. Director-General of the WHO, Tedros According to Adhanom Ghebreyesus, the word is a combination of the terms "CO" for corona, "VI" for virus, "D" for disease, and "19," which stands for the year the epidemic was first discovered (December 31, 2019) [2]. Tedros Adhanom Ghebreyesus, Director-General of the WHO, underscored the challenge of conducting numerous small trials for the coronavirus vaccine with diverse methodologies, potentially lacking adequate evidence. As a result, the WHO and its partners are coordinating a study, known as the SOLIDARITY Trial, to compare untested treatments across various countries. Tedros Adhanom Ghebreyesus emphasized the trial's extensive international scope and its purpose of generating robust data on the most effective treatments [3].
Keywords :
Cite : Sharma, N., & Das, A. (2023). Solidarity Clinical Trial For Covid-19 Treatment-A Systematic Review (1st ed., p. 62). Noble Science Press. https://doi.org/10.52458/9789388996990.2023.eb.ch-16
References :
World Health Organization. (2020). Solidarity” clinical trial for COVID-19 treatments.
World Health Organization. (2020). Naming the coronavirus disease (COVID-19) and the virus that causes it. Brazilian Journal of Implantology and Health Sciences, 2(3).
Toumi, M., Liang, S., Dabbous, M., Wang, Y., Qiu, T., & Han, R. (2020). COVID-19: Why SOLIDARITY and DisCoVeRy trials may fail to bring informative and timely results. medRxiv, 2020-06.
